Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01378871
Recruitment Status : Completed
First Posted : June 23, 2011
Last Update Posted : September 6, 2019
Sponsor:
Information provided by (Responsible Party):
Amit Verma, Albert Einstein College of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2013
Actual Study Completion Date : January 2013
Publications: